AIDS Vaccines

Vaccine Strategy Promises HIV Containment

Published in AIDS Weekly, May 17th, 1999

Elegant primate experiments point the way to a vaccine that can contain, but not prevent, HIV infection.

Monkeys primed with intradermal HIV DNA and boosted with recombinant fowlpox virus (rFPV)-expressed HIV protein developed very low-level infections but remained disease free after challenge with pathogenic SHIV (chimeric virus with an HIV coat over an SIV backbone). Deployment of such a vaccine in areas with a high incidence of infection would be expected to greatly reduce HIV transmission as well as AIDS morbidity and mortality.

"The ability to achieve stringent containment of serial SHIV challenges using intradermal DNA priming and recombinant...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1999-05-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry